235 related articles for article (PubMed ID: 23090625)
1. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.
Takano A; Halldin C; Farde L
Psychopharmacology (Berl); 2013 Mar; 226(1):147-53. PubMed ID: 23090625
[TBL] [Abstract][Full Text] [Related]
2. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
[TBL] [Abstract][Full Text] [Related]
3. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ
Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476
[TBL] [Abstract][Full Text] [Related]
4. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.
Finnema SJ; Halldin C; Bang-Andersen B; Bundgaard C; Farde L
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4159-67. PubMed ID: 25980484
[TBL] [Abstract][Full Text] [Related]
5. Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.
Owens MJ; Krulewicz S; Simon JS; Sheehan DV; Thase ME; Carpenter DJ; Plott SJ; Nemeroff CB
Neuropsychopharmacology; 2008 Dec; 33(13):3201-12. PubMed ID: 18418363
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
[TBL] [Abstract][Full Text] [Related]
7. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM
Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.
Gould GG; Altamirano AV; Javors MA; Frazer A
Biol Psychiatry; 2006 Mar; 59(5):408-14. PubMed ID: 16140280
[TBL] [Abstract][Full Text] [Related]
9. Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.
Vickers T; Dyck B; Tamiya J; Zhang M; Jovic F; Grey J; Fleck BA; Aparicio A; Johns M; Jin L; Tang H; Foster AC; Chen C
Bioorg Med Chem Lett; 2008 Jun; 18(11):3230-5. PubMed ID: 18468895
[TBL] [Abstract][Full Text] [Related]
10. Serotonin and Norepinephrine Transporter Occupancy of Tramadol in Nonhuman Primate Using Positron Emission Tomography.
Arakawa R; Takano A; Halldin C
Int J Neuropsychopharmacol; 2019 Jan; 22(1):53-56. PubMed ID: 30346535
[TBL] [Abstract][Full Text] [Related]
11. NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo.
Takano A; Nag S; Gulyás B; Halldin C; Farde L
Psychopharmacology (Berl); 2011 Jul; 216(2):279-86. PubMed ID: 21336575
[TBL] [Abstract][Full Text] [Related]
12. Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.
Aldosary F; Norris S; Tremblay P; James JS; Ritchie JC; Blier P
Int J Neuropsychopharmacol; 2022 Apr; 25(4):283-292. PubMed ID: 34958348
[TBL] [Abstract][Full Text] [Related]
13. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF
J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717
[TBL] [Abstract][Full Text] [Related]
14. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD.
Ding YS; Naganawa M; Gallezot JD; Nabulsi N; Lin SF; Ropchan J; Weinzimmer D; McCarthy TJ; Carson RE; Huang Y; Laruelle M
Neuroimage; 2014 Feb; 86():164-71. PubMed ID: 23933039
[TBL] [Abstract][Full Text] [Related]
15. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
Muneoka K; Shirayama Y; Takigawa M; Shioda S
Neurochem Res; 2009 Mar; 34(3):542-55. PubMed ID: 18751896
[TBL] [Abstract][Full Text] [Related]
16. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
Psychopharmacology (Berl); 2006 Sep; 188(1):119-27. PubMed ID: 16896954
[TBL] [Abstract][Full Text] [Related]
17. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
Stahl SM; Grady MM; Moret C; Briley M
CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
[TBL] [Abstract][Full Text] [Related]
18. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor.
Smith JA; Bourdet DL; Daniels OT; Ding YS; Gallezot JD; Henry S; Kim KH; Kshirsagar S; Martin WJ; Obedencio GP; Stangeland E; Tsuruda PR; Williams W; Carson RE; Patil ST
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522383
[TBL] [Abstract][Full Text] [Related]
19. Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.
Dyck B; Tamiya J; Jovic F; Pick RR; Bradbury MJ; O'Brien J; Wen J; Johns M; Madan A; Fleck BA; Foster AC; Li B; Zhang M; Tran JA; Vickers T; Grey J; Saunders J; Chen C
J Med Chem; 2008 Nov; 51(22):7265-72. PubMed ID: 18954038
[TBL] [Abstract][Full Text] [Related]
20. Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2.
Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asami Y; Hirano Y; Halldin C; Lundberg J
Int J Neuropsychopharmacol; 2019 Apr; 22(4):278-285. PubMed ID: 30649319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
